Other papers submitted by: Dr Viola Zhu

open access to scientific and medical research

News:

Expressions of interest for Editor-in-Chief - the International Medical Case Reports Journal Read more

Back to User profile » Dr Viola Zhu

Papers published by Dr Viola Zhu:

Case Series

Highly-accessed

Symptomatic CNS Radiation Necrosis Requiring Neurosurgical Resection During Treatment with Lorlatinib in ALK-Rearranged NSCLC: A Report of Two Cases

Zhu VW, Nagasaka M, Kubota T, Raval K, Robinette N, Armas O, Al-Holou W, Ou SI

Lung Cancer: Targets and Therapy 2020, 11:13-18

Published Date: 14 January 2020

Case report

Noteworthy comment: There are several problems arising from TKIs resistance mechanisms in patients with EGFR-mutant squamous cell carcinoma of the lung. This case report adds to evidence that dual therapy (Osimertinib and Crizotinib) should be useful to EGFR-mutant lung cancers with emergent MET amplification as acquired resistance. This is a very well written case, which would be of interest to many specialties, with a clear discussion and relevant references.

Highly-accessed

Differential response to a combination of full-dose osimertinib and crizotinib in a patient with EGFR-mutant non-small cell lung cancer and emergent MET amplification

Zhu VW, Schrock AB, Ali SM, Ou SI

Lung Cancer: Targets and Therapy 2019, 10:21-26

Published Date: 12 March 2019

Case report

Highly-accessed

Dramatic response to alectinib in a lung cancer patient with a novel VKORC1L1-ALK fusion and an acquired ALK T1151K mutation

Zhu VW, Schrock AB, Bosemani T, Benn BS, Ali SM, Ou SI

Lung Cancer: Targets and Therapy 2018, 9:111-116

Published Date: 8 November 2018